Dr Hamilton-Williams holds a Career Development Fellowship from the Juvenile Diabetes Research Foundation. She completed her PhD at the John Curtin School of Medical Research, Canberra in 2001. There she performed studies investigating the role of MHC class I expression and CD8+ T-cells in the pathogenesis of type 1 diabetes resulting in two publications in PNAS. She then undertook postdoctoral training in Germany to further study the mechanisms of tolerance induction in CD8+ T-cells. In 2005, she was awarded a Juvenile Diabetes Research Foundation (JDRF) postdoctoral fellowship and moved to the Scripps Research Institute in San Diego in the laboratory of Prof Linda Sherman. There she continued to pursue her interest in the genetic control of CD8+ T-cell tolerance in type 1 diabetes. In 2012, she returned to Australia to set up her own laboratory at the University of Queensland Diamantina Institute funded by the NHMRC. Her laboratory now focuses on the role of the microbiota in type 1 diabetes and a number of immunotherapeutic approaches aimed at restoring immune tolerance in type 1 diabetes.
Abstracts this author is presenting: